Alcon Inc. (LON:0A0D)

Market Cap	29.12B
Revenue (ttm)	7.58B
Net Income (ttm)	778.91M
Shares Out	n/a
EPS (ttm)	1.56
PE Ratio	37.38
Forward PE	23.90
Dividend	0.25 (0.40%)
Ex-Dividend Date	May 13, 2025

Volume	193,254
Average Volume	332,680
Open	63.78
Previous Close	64.57
Day's Range	63.34 - 64.80
52-Week Range	57.70 - 86.98
Beta	0.69
RSI	51.73
Earnings Date	Feb 24, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,599
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A0D

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD